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Abstract
Background: Polygonum hydropiper L. is widely used as a traditional remedy for the treatment of dysentery,
gastroenteritis. It has been used to relieve swelling and pain, dispel wind and remove dampness, eliminate
abundant phlegm and inflammatory for a long time. Previous study showed that antioxidants especially
flavonoids pretreatment alleviated sepsis-induced injury in vitro and in vivo. In the present study, the possible
anti-inflammatory effect of flavonoids from normal butanol fraction of Polygonum hydropiper L. extract (FNP)
against inflammation induced by lipopolysaccharide (LPS) was evaluated in vivo and in vitro.
Methods: The content of total flavonoid of FNP was determined by the aluminum colorimetric method. The
content of rutin, quercetin and quercitrin was determined by HPLC method. Mice received FNP orally 3 days
before an intra-peritoneal (i.p.) injection of lipopolysaccharide (LPS). Total superoxidase dismutase (T-SOD),
total antioxidant capacity (T-AOC), glutathione peroxidase (GSH-PX), glutathione (GSH), myeloperoxidase (MPO)
and malondialdehyde (MDA) levels were measured. Tumor necrosis factor-α levels in serum and tissue was
measured. mRNA expressions of pro-inflammatory cytokines in lung were assessed by Real-Time PCR.
Histopathological changes were evaluated in lung, ileum and colon. We also investigated FNP on reactive
oxygen species (ROS), nitric oxide (NO) and pro-inflammatory cytokines (TNF-α, IL-1β, IL-6 and IL-8)
production, inducible nitric oxide synthase (iNOS), Cyclooxygenase-2 (COX-2) protein expression,
phosphorylation of MAPKs and AMPK in LPS-stimulated RAW264.7 cells.
Results: FNP increased the levels of T-SOD, T-AOC, GSH-PX and GSH, decreased the levels of TNF-α, MPO and
MDA, attenuate the histopathological lesion in LPS-stimulated mice. FNP inhibited production of inflammatory
cytokines, ROS and NO, protein expressions of iNOS and COX-2, phosphorylation of ERK, JNK and c-JUN in
MAPKs, promoted phosphorylation of AMPKα suppressed by LPS.
Conclusion: These results suggested in vivo anti-inflammatory activities of FNP might contributed to its
enhancement in antioxidant capacity, its inhibitory effects may be mediated by inhibiting the phosphorylation
of JNK, ERK and c-JUN in MAPKs signaling pathways.
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Background
Sepsis, a systemic inflammatory response syndrome in-
duced by infection [1], is the most common cause of
death in intensive care units [2–4]. It can be defined as a
systemic inflammatory disorder and characterized clinic-
ally by fever [5], enteritis [6] and acute pneumonia [7].
Previous studies have established that dysfunction of
neutrophils granulocyte [8], microcirculation disorder
[9], mitochondria dysfunction [10] and translocation of
endotoxin [11] are involved in the sepsis course. To in-
vestigate the underlying mechanisms of clinical sepsis
shock and develop an effective therapeutic strategies to
endotoxin challenge, bacterial LPS, the outer membrane
component of gram-negative bacterial cell walls [12], is
widely used to induce experimental endotoxemia in la-
boratory animals. Antioxidants alleviated sepsis-induced
organ injury. In septic rats and pigs, treatment with N-
acetylcysteine did protect rats and pigs against oxidative
stress and improves survival rate [13, 14]. Ferulic acid, a
well-established natural antioxidant, increased the GSH
levels and SOD and GSH-PX activities, decreased the
MDA levels and DNA damage in the sepsis-induced rats
[15]. Therefore, agents with antioxidant activity that
suppress the production of inflammatory cytokines and
inflammatory mediators may have therapeutic effects.
Macrophages are mainly responsible for initiating the
immune defense and inflammatory reactions. Previous
research indicated that LPS-induced iNOS and COX-2
expression in macrophages are regulated by mitogen-
activated protein kinases (MAPKs), including extracellu-
lar signal regulated kinase (ERK), c-Jun N terminal
kinase (JNK), and p38 [16]. Among them, JNK MAPKs
pathway is crucial for macrophage activation and the
production of inflammatory cytokines [17]. A wide var-
iety of flavonoid molecules possess anti-inflammatory
activity in LPS-induced macrophage by regulating
MAPKs signaling pathway [18–20]. Fenoterol inhibits
LPS-induced AMPK activation and IL-1β production,
AMPKα1 subunit contributed to LPS-induced release of
pro-inflammatory cytokines in THP-1 cells [21]. There-
fore, treatments aimed at regulating AMPK and MAPKs
may have potential therapeutic advantages for inflamma-
tory diseases.
The folk medicinal plant, Polygonum hydropiper L.
which is widely used in East Asian countries for centur-
ies, especially in Korea, Japan and China. Flavonoids iso-
lated from methanol extract of Polygonum hydropiper L.
leaves showed strong antioxidant activity [22, 23]. Quer-
cetin was found as one of the active ingredients in 99 %
methanol extracts of this plant to inhibits NO and PGE2
production in LPS-treated macrophages [24]. Consider-
ing the antioxidant activity and anti-Inflammatory activ-
ity of the Polygonum hydropiper L., it is surprising that
no pharmacological study has been performed for
investigating the protective effect on LPS-induced sepsis
in vivo. We hypothesize that flavonoids of Polygonum
hydropiper L. might has an anti-inflammatory activity.
However, there is no scientific evidence, which validate
its use in the literature. Therefore, the aim of the present
study is to evaluate whether the flavonoids of normal
butanol extract from Polygonum hydropiper L.have ac-
tions on the production of inflammatory mediators from
macrophage so as to inhibit inflammation and protect
mice against LPS-induced sepsis.
Methods
Materials and reagents
LPS (Escherichia coli 055:B5) was purchased from Sigma
Chemical Co. (St. Louis, USA). Foetal bovine serum and
Dulbecco Modified Eagle Mediumas (DMEM) was pur-
chased from Gibco (New York, USA). 3-(4, 5-
Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT) and Fluorescent probe dichlorofluorescin diace-
tate (DCFH-DA) for ROS dection were purchased from
Applygen (Beijing, PR China). Mouse TNF-α, IL-6, IL-8,
IL-10 and IL-1β enzyme-linked immuno sorbent assay
(ELISA) kits were purchased from Neobioscience
(Shenzhen, PR China). RAW264.7 cells were purchased
from the Type Culture Collection of Chinese Academy
of Sciences (Shanghai, PR China). Assay kits for NO, T-
SOD, T-AOC, GSH-PX, GSH, lysozyme (LZM), acid
phosphatase (ACP), MPO, MDA dection were purchased
from the Institute of Nanjing Jiancheng Bioengineering
(Nanjing, PR China). RNAiso Plus Kit, PrimeScript® RT
reagent Kit (Perfect Real Time) and SYBR® Premix Ex
TaqTM II Kit (Perfect Real Time) used in RT-qPCR
were purchased from Takara Biotechnology (Dalian, PR
China). Cell culture dishes and plates (12 mm polycar-
bonate membrane, 0.4 μm pore size, 1.12 cm2 surface
area) were purchased from Corning (New York, USA).
iNOS (D6B6S), COX-2 (D5H5), MAPKs Family Anti-
body Sampler Kit, phospho-MAPKs Family Antibody
Sampler Kit, c-JUN (60A8), phospho-c-JUN (Ser 3),
AMPKα (D5A2), phospho-AMPKα (40H9), β-Actin
(13E5) and GADPH (14C10) were obtained from Cell
Signaling Technology (Beverly, USA).
Herbal extract preparation
Polygonum hydropiper L. was purchased from Tai Hua
pharmaceutical Co. Ltd. The plant material was authen-
ticated by Professor Renbin Huang, School of Pharmacy,
Guangxi medical University. The voucher specimen
(2010–125) has been deposited at the Herbarium of
Faculty of Pharmacy, Guangxi medical University for fu-
ture reference. The extraction and purification of FNP
were carried out as followed. Briefly, the air-dried whole
plant (500 g) was ground to a powder and extracted with
ultrasonic in a buffered solution(Hac-NaAc pH 4.8,1.5 l)
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added with cellulase and pectinase (0.25 % W/V respect-
ively) at 50 °C for 1.5 h. Then the pH value was adjusted
to 9.0 with sodium carbonate solution and the enzyme
was inactivated at 85 °C water bath for 15 min, and then
macerated with ethanol for 24 h. The extracts were fil-
tered and residue were extracted by maceration in etha-
nol. The combined filtrate was evaporated under reduced
pressure to obtain a crude extract (yield 52.3 %) and suc-
cessively treated with petroleum ether (40–60 °C), chloro-
form, ethyl acetate and normal butanol. The normal
butanol fraction yield was 11.96 %. The normal butanol
fraction was added into column loading-treated XDA-8
macroreticular resin for adsorption for 24 h, and then
washed with water and 20 % ethanol, respectively, to get
rid of polar impurities. FNP in the column was eluted with
75 % ethanol, and the eluting solution was dried in vac-
uum condition until yellow powders were achieved.
Quality control of FNP
Approximately 100 mg of FNP were transferred to a 10
mL volumetric flask and diluted with methanol to volume.
The test sample was finally filtered through a 0.45 μm
membrane filter before analysis. The total flavonoids con-
tent was determined using a colorimetric method as previ-
ously described but with slightly modified [25]. Briefly, 1.0
mL of NaNO2 solution (5 %, w/v), 1.0 mL of AlCl3 solu-
tion (10 %), and 4.0 mL NaOH solution (1.0 mol/L) were
mixed with the same volume of the test sample. The final
volume was adjusted to 25 mL with methanol (80 %, v/v).
The mixture was allowed to stand for 5 min and the ab-
sorbance was measured at 510 nm against the same mix-
ture, without the sample as a blank. Rutin was used as a
reference standard and the total flavonoids content was
expressed as rutin. The calibration curve (Y = 0.0011X +
0.00125 where X was absorbance value of sample, and Y
was sample concentration) was ranged from 100 to 500
μg/mL (R2 = 0.9992). The contents of three markers
(rutin, quercetin and quercitrin) in the extract samples
were determined by High Performance Liquid Chroma-
tography (HPLC) using followed chromatographic condi-
tion: Waters e2695 separation module and Waters 2998
photodiode array detector were controlled by EM-
POWER™ 2 chromatography data sofeware (Waters Co.
Ltd. USA). Waters X Bridge™ C18 HPLC column (4.6 ×
250 mm 5 μm, Waters Co. Ltd. USA). Column
temperature was kept constantly at 30°C. UV detection
wavelength was 254 nm. The injection volume was 10 μL.
The isocratic mobile phase consisted of acetonitrile-0.3 %
phosphoricacid (27:73, v/v) was used to elute for 40 min
and the flow rate was kept at 1.0 mL/min.
Animals
The study protocol was approved by the Ethics Commit-
tee of Guangxi University and was performed in
accordance with the Guiding Principles for the Care and
Use of Laboratory Animals. Male special pathogen free
KM mice were obtained from the Laboratory Animals
Center of Guangxi Medical University (Certificate No.
2011–002). After three days of acclimatization, 50 mice
were randomly divided into five groups of 10 mice each.
Mice in the LPS alone group were injected intraperito-
neally with 17 mg/kg (body weight) of Escherichia coli
LPS (Serotype 055:B5, Sigma) in phosphate-buffered sa-
line (PBS) [26], while control mice were injected with
only PBS (10 mL/kg). The animals in FNP50, FNP100
and FNP200 group were orally administrated with di-
verse dose FNP (50 mg/kg, 100 mg/kg or 200 mg/kg) for
3 days before instillation of LPS. All mice were eutha-
nized at 24 h after LPS or PBS instillation, and the sam-
ples were collected for subsequent analysis.
Mortality and measurement of TNF-α values
The mortality of mice was recorded for 24 h after the
LPS challenge in each treated group. Homogenates of
murine liver and intestine were prepared using
physiological saline (1:9, w/v ratio) and kept on an
ice bath. The homogenates were then centrifuged at
1,000 g at 4 °C for 15 min, and the supernates were
collected. Blood samples were collected and the TNF-
α levels in serum and supernates was analyzed using
a cytokine-specific ELISA kit according to the manu-
facturer’s protocol.
Biochemical analysis
Homogenates of murine small intestine were prepared
using physiological saline (1:9, w/v ratio) and kept on
an ice bath. The homogenates were then centrifuged at
1,000 g at 4 °C for 15 min, and the supernates were
collected and analyzed for MPO activities and MDA
levels. Homogenates of murine liver were prepared
using physiological saline (1:9, w/v) and kept on an ice
bath. The homogenates were then centrifuged at 1,000
g at 4 °C for 15 min, and the supernates were collected
and analyzed for T-SOD, T-AOC and GSH-PX activ-
ities. Blood samples were collected and the serum were
then centrifuged at 1,000 g at 4 °C for 15 min, and the
supernates were collected and analyzed for levels of
LZM, ACP and GSH.
Quantification of messenger RNA (mRNA) in lung of mice
Total RNA was extracted from lung tissues by using
RNAiso Plus Kit, and RNA was reverse transcribed to
cDNA using reverse transcription and amplified by PCR
with PrimeScript® RT reagent Kit according to the man-
ufacturer’s instructions. Relative expression of TNF-
α、IFN-α、IFN-γ and IL-2 were measured with a
SYBER green detection system by using CFX96 Real-
Time PCR Detection System (Bio-Rad, USA), Each
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reaction was run in triplicate and the cycle threshold
(CT) values for each mRNA were subtracted from that
of β-actin mRNA averaged and converted from log-
linear to linear term. The primer sequences used were as
follows: TNF-α (NM_013693): forward: 5'-AAGACCTC
TATGCCAACACAGT-3' and reverse: 5'-TTTACTC
AGTGCCAGAAGCTGGA-3’; IL-2 (NM_008366.3): for-




IFN-γ (NM_00801778): forward: 5'-GCTTTGCAG





To characterize the histological alterations, the lungs,
ileum and colon of the mice were excised and fixed in
10 % neutral buffered formalin. The tissue samples were
dehydrated with graded alcohol, embedded in paraffin,
and the sections stained with hematoxylin and eosin
were examined by light microscopy.
Cell culture and treatments
Mouse macrophage RAW 264.7 cells were cultured in
DMEM supplemented with 10 % heat-inactivated fetal bo-
vine serum,100 units/mL penicillin sodium, 100 μg/mL
strepto-mycin and 2 mmol/L glutamine at 37 °C under a
humidified atmosphere of 5 % CO2. In all experiments,
cells were allowed to acclimate for 24 h before any treat-
ment. Cells were incubated with or without FNP that was
added 1 h prior to LPS treatment.
MTT assay for testing cell viability
The examination of cytotoxicity induced by FNP was
performed by MTT assay [27]. RAW 264.7 cells were
mechanically scraped, plated at a density of 2 × 105 cells
/mL into 96-well plates and incubated in a 37 °C, 5 %
CO2 incubator overnight. FNP was dissolved in Di-
methyl Sulphoxide (DMSO), and the DMSO concentra-
tions in all assays was not exceed 0.1 %. After overnight
incubation, the cells were treated with diverse concen-
trations of FNP (20–400 μg/mL) in the presence or ab-
sence of LPS (1 μg/mL) according to the experimental
design. After 20 h, 20 μL of 5 mg/mL MTT was added
to each well and the cells were further incubated for an
additional 4 h. MTT was removed and cells were lysed
with 150 μL/well DMSO. The optical density was mea-
sured at 570 nm on a microplate reader.
Measurement of NO production
After pre-incubation of RAW264.7 cells (1 × 106 cells/
mL) for 18 h, cells were pre-treated with FNP (20–80
μg/mL) for 1 h and were further incubated with LPS (1
μg/mL) for 12 h or 24 h. The inhibitory effect of FNP on
NO production was determined by Griess reagent as de-
scribed previously [28].
Measurement of ROS levels
After pre-incubation of RAW264.7 cells (1 × 106 cells
/mL) for 18 h, the cells were pre-treated with FNP
(20, 40 or 80 μg/mL) for 1 h and were further incu-
bated with LPS (1 μg/mL) for 12 h or 24 h. The in-
hibitory effect of FNP on ROS production was
determined by fluorescent probe DCFH-DA as de-
scribed previously [29].
Measurement of inflammatory cytokine values
To investigate the effect of FNP on inflammatory cyto-
kine levels from LPS-treated RAW 264.7 cells, The pre-
incubated cells (1 × 106 cells /mL) were pretreated with
20, 40 or 80 μg/mL of FNP for 1 h prior to 1 h treat-
ment with 1 μg/mL LPS at 37 °C, 5 % CO2 incubator.
24h later post LPS treatment, cell-free supernatants were
collected and stored at −20 °C until assayed for cytokine
levels. The concentrations of TNF-α, IL-6, IL-8, IL-10
and IL-1β in the supernatants of RAW 264.7 cell culture
were determined by a cytokine-specific ELISA kit, ac-
cording to the manufacturer’s instructions.
Western blot analysis
RAW 264.7 cells (2 × 105 cells/mL) were plated in 24-
well plates and pretreated with 20 μg/ mL or 80 μg/ mL
of FNP for 2 h or 4 h and then stimulated with 1 μg/mL
of LPS for 1 h. After incubation, the cells were collected
and washed twice with cold PBS. The washed cell pellets
were resuspended in extraction lysis buffer (1:10 10 ×
RIPA Buffer(CST,USA),1:10 cOmplete ULTRA EDTA-
free protease inhibitor cocktail tablets (Roche, Swiss),
1:10 PhosSTOP Phosphatase Inhibitor Cocktail Tablets
(Roche, Swiss)) and maintained on ice for 30 min. The
lysates were centrifuged (12,000 g at 4 °C) for 5 min to
obtain the cytosolic fraction and the protein concentra-
tions were determined using a BCA™ protein assay kit
(Cwbiotech, China) according to the manufacturer’s in-
structions. Aliquots of the cell extracts (50 μg of protein)
were separated on 10 % SDS-polyacrylamide gel and
transferred onto a polyvinylidene fluoride (PVDF)
membrane (Roche, Swiss) with a glycine transfer buffer
[192 mM glycine, 25 mM Tris–HCl (pH 8.8), 10 %
methanol (v/v)]. The membrane was incubated overnight
with specific primary antibody(CST,USA) at 4 °C after
blocking the nonspecific site with 5 % bovine serum al-
bumin (BSA). The membrane were washed with Tween
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20/Tris buffered saline [TTBS, 20 mM Tris–HCl buffer,
pH 7.6, containing 137 mM NaCl and 0.05 % (v/v)
Tween 20] and incubated an additional 60 min with a
peroxidase-conjugated secondary anti-mouse anti-
body(1:5000 CST,USA) at room temperature. The mem-
branes were washed with TTBS twice and the
immunoactive proteins were detected using an enhanced
chemiluminescence (ECL) Western blotting detection
kit (Merck Millipore, Germany).
Statistical analysis
All experimental data in this study was represented as
mean ± SD. All statistical comparisons were conducted
using oneway ANOVA followed by Tukey’s test and
analyzed using SPSS 16.0 for Windows. Difference
was considered statistically significant when P < 0.05,
whereas less than 0.01 were considered extremely sig-
nificant (P < 0.01).
Results
Quality evaluation of FNP
The content of total flavonoids in the extract was deter-
mined quantitatively as 55.3 % by colorimetric method
by using rutin as the standard. The contents of rutin,
quercetin and quercitrin in the extract detected by
HPLC analysis (Fig. 1) is 21.9 %, 8.2 % and 20.6 %,
respectively.
FNP reduced mortality and pathological damages in LPS-
stimulated mice
First, we examined the effect of FNP (50, 100 or 200
mg/kg oral administration) on LPS (17 mg/kg, intraperi-
toneally) induced mortality for 24 h in mice. No mice
were dead in control group while LPS treated alone
caused 30 % mortality within 24 h. Pretreated with FNP
significantly reduced LPS induced death. No mice were
dead while pretreated with FNP. As shown in Fig. 2, no
obvious histopathological change was found in lung
Fig. 1 HPLC analysis of FNP. Notes: The isolated compounds were identified in the extract by comparing their retention times. The
chromatograms were obtained at a wavelength of 254nm. (1) rutin (2) quercitrin (3) quercetin
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from control group (Fig. 2a). Remarkable incrassation of
alveolar wall, serous exudation, hemorrhage and infiltra-
tion of polymorphonuclear neutrophil (PMN) was pre-
sented in LPS-treated group (Fig. 2b). No serous
exudation and hemorrhage, less incrassation of alveolar
wall and less infiltration by PMN was shown in FNP
pretreated groups (Fig. 2c) as compared with LPS-
treated group. No obvious histopathological change was
Fig. 2 Protective effect of FNP on lung, ileum and colon in LPS-stimulated mice. Notes: The mice in the LPS group were injected intraperitoneally
with 17 mg/kg (body weight) of LPS, while control group were injected with PBS (10 mL/kg). FNP50, FNP100 and FNP200 group were orally
administrated with diverse dose FNP (50 mg/kg, 100 mg/kg and 200 mg/kg) for 3 days before instillation of LPS. Histopathological studies by light
microscope showing morphologically normal lung, ileum and colon tissues from mice in the control group (a, d and g). Incrassation of alveolar
wall, serous exudation, hemorrhage and infiltration of PMN in lung from LPS-treated group (b) and no serous exudation or hemorrhage and less
incrassation of alveolar wall and infiltration by PMN in lung from LPS-treated mice treated with FNP (c). Necrosis of epithelial cell, disorder of
epithelial cell arrangement and fall of epithelium of intestinal villus in ileum and colon from LPS-treated group (e and h) and less necrosis of
epithelial cell in ileum and colon from LPS-treated mice treated with FNP (f and i). Tissue sections were stained with hematoxylin and eosin and
view by light microscopy (200 and 400×)
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found in ileum from control group (Fig. 2d). Necrosis of
epithelial cell, disorder of epithelial cell arrangement and
fall of epithelium of intestinal villus was presented in
LPS-treated group (Fig. 2e). Less epithelial cell necrosis
and less fall of epithelium of intestinal villus was shown
in FNP pretreated groups (Fig. 2f ) as compared with
LPS-treated group. No obvious histopathological change
was found in colon from control group (Fig. 2g). Indis-
tinct villus border, necrosis of epithelial cell, disorder of
epithelial cell arrangement and fall of epithelium of in-
testinal villus was presented in LPS-treated group
(Fig. 2h). Less epithelial cell necrosis and less fall of
epithelium of intestinal villus was shown in FNP pre-
treated groups (Fig. 2i) as compared with LPS-treated
group.
FNP reduced TNF-α levels in blood and tissues in LPS-
stimulated mice
As shown in Fig. 3a, mice with LPS treated alone re-
sulted in significant increases in TNF-α production in
serum, liver and intestine homogenates as compared to
the control group. The production of TNF-α was 29.9 ±
4.8, 36.9 ± 3.7, 47.5 ± 3.6 ng/L respectively. However, the
production of TNF-α in serum, liver and intestine
Fig. 3 Effects of FNP pretreatment on TNF-α levels in blood and tissues, mRNA expression in lung. Notes: The mice in the LPS group were
injected intraperitoneally with 17 mg/kg (body weight) of LPS, while control group were injected with PBS (10 mL/kg). FNP50, FNP100 and
FNP200 group were orally administrated with diverse dose FNP (50 mg/kg, 100 mg/kg and 200 mg/kg) for 3 days before instillation of LPS. Serum
and lung were collected, liver and intestine homogenates were prepared. TNF-α levels of serum and homogenates were shown in (a). The level
of mRNA expression in lung is expressed as fold-change relative to the control group (b). The mRNA expression of TNF-α, IFN-α, IFN-γ and IL-2
was analyzed by qRT-PCR. Data are presented as the means ± SD from three independent experiments (n = 10). ##P <0.01 vs control group;
*P <0.05 vs LPS group; **P <0.01 vs LPS group
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homogenates was significantly inhibited as pretreated
with FNP as compared with LPS-treated group. FNP
pretreatment (200 mg/kg) reduced this TNF-α level by
68.7 %, 28.5 % and 34.1 % respectively. These results
show FNP reduced TNF-α levels on LPS-stimulated
mice.
FNP down regulated mRNA expression in lung in LPS-
stimulated mice
The effects of FNP on TNF-α, IFN-α, IFN-γ, IL-2 and
IL-10 mRNA expressions were detected by qRT-PCR. As
shown in Fig. 3b, mice with LPS treated alone resulted
in significant increases in TNF-α (43.4 ± 1.5), IFN-α
(21.8 ± 1.8), IFN-γ (58.6 ± 4.2) and IL-2 (46.4 ± 1.5)
mRNA expression levels in lung as compared to the
control group. However, pretreated with FNP (50, 100 or
200 mg/kg) significantly decreased mRNA expression
level of TNF-α, IFN-γ and IL-2 as compared to the LPS-
treated group. FNP did not inhibited mRNA expressions
of IFN-α induced by LPS.
FNP increased antioxidant capacity in LPS-stimulated
mice
As shown in Fig. 4a and 4b, mice with LPS treated alone
resulted in significant increases in MDA (9.6 ± 1.5 nmol/
mgprot) and MPO (1.6 ± 0.2 U/g) production in small
intestine homogenates as compared to the control
group. The MDA and MPO level was increased by 247.6
% and 216.1 % as compared to the control group re-
spectively. However, the production of MDA in small in-
testine homogenates was significantly inhibited as
pretreated with FNP (50, 100 and 200 mg/kg) as com-
pared with LPS-treated group, the MDA level was de-
creased by 29.6 %, 36.1 % and 45.1 % respectively.
Pretreated with FNP (50, 100 and 200 mg/kg) signifi-
cantly inhibited the increase of MPO in small intestine
homogenates as compared with LPS-treated group, the
MPO level was decreased by 19.6 %, 62.5 % and 63.7 %
respectively.
As shown in Fig. 4c, no significant difference but a
decrease was shown in T-AOC level between LPS-
treated group and control group. However, the level
of T-AOC in liver homogenates was significantly pro-
moted as pretreated with FNP at the dose of 200 mg/
kg as compared with LPS-treated group, the T-AOC
level was increased by 36.1 %. As shown in Fig. 4d,
mice with LPS treatment alone resulted in significant
decreases in T-SOD (107.3 ± 24.7 U/mgprot) activity
in liver homogenates as compared to the control
group, the T-SOD level was decreased by 26.2 %.
However, pretreated with FNP (100 and 200 mg/kg)
significant increases T-SOD activities as compared to
the LPS-treated group, the T-SOD level was increased
by 54.6 % and 87.2 % respectively. As shown in
Fig. 4e, mice with LPS treatment alone resulted in
significant decreases in GSH-PX (379.7 ± 64.8 U/
mgprot) activities in liver homogenates as compared
to the control group, the GSH-PX level was decreased
by 34.2 %. However, pretreated with FNP (50, 100
and 200 mg/kg) significant increases GSH-PX level as
compared to the LPS-treated group, the GSH-PX
level was increased by 80.3 %, 117.5 % and 140.3 %
respectively.
As shown in Fig. 4f, no significant difference but a de-
crease was shown in GSH level between LPS group and
control group. However, the level of GSH in serum was
significantly promoted as pretreated with FNP (50, 100
and 200 mg/kg) as compared with LPS-treated group,
the GSH level was increased by 29.2 %, 59.3 % and 168.0
% respectively. As shown in Fig. 4g, mice with LPS treat-
ment alone resulted in significant increases in ACP
(119.5 ± 19.3 king unit/100 mL) level in serum as com-
pared to the control group, the ACP level was increased
by 70.9 %. However, pretreated with FNP (100 and 200
mg/kg) significantly decreased ACP level as compared to
the LPS-treated group, the ACP level was decreased by
27.4 % and 29.3 % respectively. As shown in Fig. 4h, no
significant difference but a decrease was shown in LZM
level between LPS group and control group. However,
pretreated with FNP (50, 100 and 200 mg/kg) signifi-
cantly increased LZM level as compared to the LPS-
treated group, the LZM level was increased by 71.0 %,
172.5 % and 195.4 % respectively.
Effects of FNP on RAW 264.7 macrophage viability
To assess the suitable concentration of FNP for the ex-
periment, RAW 264.7 cells were incubated with FNP at
concentrations ranging from 20 to 400 μg/mL and cell
viability was measured by MTT test 24 h later. FNP at
concentrations from 20 to 300 μg/mL had no cytotoxic
effect on RAW 264.7 cells. An extremely higher cell
viability was observed in the cells treated with FNP at
concentration 20 μg/ml compared to the control group
(P < 0.01) (Fig. 5a), therefore, we chose 40 and 80 μg/mL
to investigate intervention effects of FNP in our further
experiment.
FNP reduced NO and ROS production in LPS-stimulated
RAW 264.7 macrophages
Nitrite concentration in the medium was determined
by using Griess reagent. ROS production was deter-
mined by fluorescent probe DCFH-DA. RAW 264.7
cells with LPS treated alone resulted in extremely sig-
nificant increases in NO production as compared to
the control group. The NO level was increased by
87.4 % as compared to control group. However, pre-
treated with FNP (80, 40 and 20 μg/mL) significantly
inhibited the production of NO in 24 h after LPS
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stimulated (Fig. 5b). The NO level was decreased by
46.5 %, 46.9 % and 46.9 % respectively. RAW 264.7
cells with LPS treated alone resulted in significant in-
creases in ROS production as compared to the con-
trol group. The ROS level was increased by 38.5 % as
compared to control group. However, the production
of ROS was significantly inhibited as pretreated with
FNP (80, 40 or 20 μg/mL) 12 h and 24 h after LPS
stimulated (Fig. 5c).
FNP reduced inflammatory cytokine production in LPS-
stimulated RAW 264.7 macrophages
Inflammatory cytokine level were determined by
cytokine-specific ELISA kit. RAW 264.7 cells with
LPS treated alone resulted in significant increases in
cytokine production (TNF-α, IL-1β, IL-6, IL-8 and IL-
10) as compared to the control group (Fig. 6a and
6b). However, the production of IL-6 was significantly
inhibited as pretreated with FNP (80, 40 and 20 μg/
Fig. 4 Effects of FNP on antioxidant capacity in LPS-stimulated mice. Notes: The mice in the LPS group were injected intraperitoneally with 17
mg/kg (body weight) of LPS, while control group were injected with PBS (10 mL/kg). FNP50, FNP100 and FNP200 group were orally administrated
with diverse dose FNP (50 mg/kg, 100 mg/kg and 200 mg/kg) for 3 days before instillation of LPS. Serum, homogenates of small intestine and
liver were prepared. (a) MDA level in small intestine. (b) MPO level in small intestine. (c) T-AOC level in liver. (d) T-SOD level in liver. (e) GSH-PX
level in liver. (f) GSH level in serum. (g) ACP level in serum. (h) LZM level in serum. Each column represented as the means ± SD from three
independent experiments (n = 10). ##P <0.01 vs control group; *P <0.05 vs LPS group; **P <0.01 vs LPS group
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mL) (Fig. 6b). The production of TNF-α and IL-1β
was significantly inhibited as pretreated with FNP (80
and 40 μg/mL) (Fig. 6a and 6b). Only pretreated by
80 μg/mL FNP significantly decreased production of
IL-8 induced by LPS (Fig. 6b). FNP pretreatment
showed no influence in production of IL-10 induced
by LPS (Fig. 6b).
Effects of FNP on iNOS and COX-2 protein expression in
LPS-stimulated RAW 264.7 macrophages
The expression levels of iNOS and COX-2 protein were
examined by Western blot analysis using β-actin as an
internal control. As shown in Fig. 7, RAW 264.7 cells
with LPS treated alone resulted in significant increases
in iNOS protein expressin, 4 h and 2 h FNP
Fig. 5 Cytotoxic effects of FNP in RAW264.7 cells (a) and the effects of FNP on LPS-induced NO (b), and ROS (c) productions in RAW264.7
macrophages. Notes: The cells were incubated for 24 h with 1 μg/mL of LPS in the absence or presence of FNP (20, 40, and 80 μg/mL). FNP was
added 1 h before incubation with LPS. Cell viability assay was performed by using MTT assay. Nitrite concentration in the medium was deter-
mined by using Griess reagent. ROS production was determined by fluorescent probe DCFH-DA. Each column represented as the means ± SD
from three independent experiments. ##P <0.01 vs control group; *P <0.05 vs LPS group; **P <0.01 vs LPS group
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Fig. 6 Effects of FNP on LPS-induced TNF-α (a) and IL-6, IL-8, IL-10 and IL-1β (b) productions in RAW264.7 macrophages. Notes: The cells were
incubated for 24 h with 1 μg/mL of LPS in the absence or presence of FNP (20, 40, and 80 μg/mL). FNP was added 1 h before incubation with
LPS. Inflammatory cytokine level were determined by cytokine-specific ELISA kit. Each column represented as the means ± SD from three
independent experiments. ##P <0.01 vs control group; *P <0.05 vs LPS group; **P <0.01 vs LPS group
Fig. 7 Effects of FNP on iNOS and COX-2 protein expression in LPS-stimulated RAW264.7 cells. Notes: The cells were pretreated with different
concentrations (40 μg/mL, 80 μg/mL) of FNP for 2 h or 4 h and stimulated with 1 μg/mL of LPS for 24 h. Total cellular proteins (50 μg) were
separated by SDS-PAGE, then transferred to PVDF membrane and detected by Western blot analysis. Quantification of iNOS and COX-2 protein
expression was normalized to β-actin using a densitometer. Each column represented as the means ± SD from three independent experiments.
##P <0.01 vs control group; *P <0.05 vs LPS group; **P <0.01 vs LPS group
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pretreatment (80 μg/mL) significantly inhibited iNOS
protein expression induced by LPS, the iNOS protein ex-
pression induced by LPS was decreased by 50.2 % and
54.8 % respectively. The expression levels of COX-2 pro-
tein were strongly induced by LPS, pretreated with FNP
(80 μg/mL) for 4 h significantly inhibited COX-2 protein
expression induced by LPS the protein expression in-
duced by LPS was decreased by 30.0 %.
Effects of FNP on LPS-induced MAPKs and AMPK
phosphorylation in LPS-stimulated RAW 264.7
macrophages
To investigate whether the inhibition of inflammatory
mediator secretion by FNP is mediated through the
MAPKs and AMPK pathway, we examined the effect
of FNP on LPS-stimulated phosphorylation of ERK,
JNK, p38 MAPKs,c-JUN and AMPKα in RAW 264.7
macrophages by Western blot analysis using phospho-
specific antibodies. Cells were pretreated with differ-
ent concentrationsof FNP for 2 h or 4 h and stimu-
lated with 1 μg/ml of LPS for 1 h. As shown in
Fig. 8b and 8c, pretreated with FNP (40 μg/mL and
80 μg/mL) for 2 h and 4 h resulted in the notably in-
hibition of LPS-induced phosphorylation of ERK, JNK
and c-JUN, whereas it did not affect p38 phosphoryl-
ation. As shown in Fig. 8c, RAW 264.7 cells with LPS
treated alone resulted in significant decreased in the
ratio of p-AMPKα/ AMPKα, pretreated with FNP for
2h not affect the ratio of p-AMPKα/ AMPKα,
whereas pretreated with FNP for 4 h notably in-
creased it (Fig. 8b).
Discussion
Catechin, epicatechin, hyperin, isoquercitrin, isorhamne-
tin, kaempferol, quercetin, quercitrin, rhamnazin and
rutin was found to contain in Various extracts and frac-
tions of Polygonum hydropiper L. whole plant and herbs
[30–32]. In this study, the content of flavonoids was de-
termined by spectrophotometry using the aluminium
chloride colorimetric method. Rutin was used as a refer-
ence standard and the flavonoid content express in μg
rutin/mL of FNP. The principle of aluminum chloride
colorimetric method is that aluminum chloride forms
acid stable complexes with the C-4 keto group and ei-
ther the C-3 or C-5 hydroxyl group of flavones and fla-
vonols [33]. Only rutin, quercetin and quercitrin were
used as standards in in the HPLC identification, so con-
tents of rutin, quercetin and quercitrin (50.7 %) were less
than total flavonoid content in FNP (55.3 %). According
to our HPLC results in chromatographic condition of
acetonitrile and 0.3 % phosphoricacid (27:73, v/v), the
contents of rutin, quercetin and quercitrin in FNP is
21.92 %, 8.22 % and 20.61 % respectively, the retention
times is 7.92 min, 26.53 min and 11.91 min. According
to the UPLC-MS identification in chromatographic con-
dition of 19 % methanol and 0.1 % formic acid, the order
of retention times of flavonoids in Polygonum hydropiper
L. was found to be as follows: rutin < hyperin <
Fig. 8 Effects of FNP on phosphorylation of MAPKs and AMPK in LPS-stimulated RAW264.7 cells. Notes: The cells were pretreated with different
concentrations (40 μg/mL and 80 μg/mL) of FNP for 2 h or 4 h and stimulated with 1 μg/ml of LPS for 1 h. Total cellular proteins (50 μg) were
separated by SDS-PAGE, then transferred to PVDF membrane and detected by Western blot analysis. Western blot results were shown in (a).
Quantification of p-AMPKα, p-ERK1/2, p-P38, p-JNK and p-c-JUN protein expression was normalized to AMPKα, ERK1/2, P38, JNK and c-JUN using
a densitometer. Each column represented as the means ± SD from three independent experiments. Results of 4h pretreatment were shown in
(b) and results of 2 h pretreatment were shown in (c). #P <0.05 vs control group; ##P <0.01 vs control group; *P <0.05 vs LPS group; **P <0.01 vs
LPS group
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isoquercitrin < quercitrin < catechin < epicatechin < quer-
cetin < kaempferol < isorhamnetin [31]. We speculated
FNP contain catechin and epicatechin.
Intraperitoneal injectetion of LPS has been used as a
common experimental inflammation model and charac-
terized by increased levels of neutrophils, protein con-
tent, inflammatory cytokines, chemokines and lung
injury [26, 34]. In the present study, as expected, mice
stimulated with LPS exhibited a high mortality. Pretreat-
ment with FNP markedly reduced the mortalities indi-
cated that FNP could significantly protect mice from
LPS-induced death. Proinflammatory cytokines includ-
ing TNF-α and IFN-γ, which playing a prominent role in
the pathogenesis of tissue injury evolving from septic
shock, are contributing to the protection of the lung
against severe damage [35]. In a Gram-positive sepsis
modle, mRNA expression levels of TNF-α and IFN-γ
significantly increase [36]. Next, we investigated the in-
hibitory effect of FNP on histological alterations and
mRNA expression levels of proinflammatory cytokines
in lung. In our study,FNP pretreatment dramatic de-
creased the mRNA expression of TNF-α, IFN-α, IFN-γ
and IL-2 induced by LPS in lung, attenuated lung injury
by decreasing alveolar incrassation and PMN infiltration.
These results showed that FNP exert a salutary effect on
acute lung injury in LPS-stimulated mice. Reactive
oxygen species have been found to have a role in the
pathogenesis of LPS-induced gastrointestinal motility
disturbances [37]. LPS injection increases the levels of
oxidative damage in plasma and intestine [38]. We in-
vestigated the inhibitory effect of FNP on MDA and
MPO levels in small intestine homogenates, histological
alterations in ileum and colon. Our results suggested
that FNP pretreatment attenuated ileum and colon injur-
ies by decreasing MDA and MPO levels, these results
showed that FNP exert a salutary effect on intestinal
damage in LPS-stimulated mice. Thus, we can draw a
conclusion that FNP exerted benefits on lung and intes-
tinal injury in LPS-stimulated mice.
The pathogenesis of sepsis involves disorders of oxi-
dant/ anti-oxidant and inflammation/anti-inflammation,
and the increased production of inflammatory cytokines.
ROS, NO and the potent proinflammatory cytokines
(such as TNF-α, IL-1β and IL-6) play an important role
in the occurrence and development of systemic inflam-
matory responses [39, 40]. Flavonoid compound derived
from natural plant inhibits the activation of macrophage
and protects mice from macrophage-mediated endo-
toxin shock [41]. In the present study, the results of in
vivo experiment showed that FNP pretreatment sup-
pressed LPS-induced TNF-α production in serum, liver
and small intestine. In addition, the results of in vitro
experiment showed that FNP pretreatment suppressed
LPS-induced inflammatory cytokines (TNF-α, IL-
1β、IL-6、IL-8), NO and ROS production in RAW
264.7 cells. Considering a critical role of ROS, NO and
inflammatory cytokines in septic shock, increased sur-
vival of mice and reduction of multiple organ injury might
be mediated by inhibition the production of ROS, NO and
inflammatory cytokines in activated macrophage.
To alleviate cumulative burden of oxidative stress,
cells generally utilize anti-oxidant defense systems to
scavenge ROS. SOD and GSH-PX are the first line of
defense against oxidative stress and can inhibit free rad-
ical formation and prevent oxidative damage by ROS
[42]. In this paper, to determine whether the protective
effects of FNP on multiple organ injury in LPS-
stimulated mice were mediated by their antioxidant
functions, the activities of antioxidant enzymes in mice
under sepsis with or without pretreatment of FNP were
investigated. In the present study, the results of in vivo
experiment showed that FNP pretreatment significantly
promoted T-AOC, T-SOD, GSH-PX and GSH levels as
compared to LPS group, suggesting that FNP pretreat-
ment significantly attenuated the oxidative damage of
LPS-stimulated mice by maintaining the activity of anti-
oxidant enzymes.
Over production of NO and PGE2 was due to overex-
pression of iNOS and COX-2. During infection, inflam-
mation injury was caused by uncontrolled release of NO,
while PGE2 was contributed to edema, angiogenesis and
invasion [43]. To explore possible mechanism of anti-
inflammatory effect by FNP pretreatment, we study its
effects on iNOS and COX-2 protein expression in LPS-
stimulated RAW264.7 cells. In the present study, our
results showed that FNP pretreatment significantly
attenuated the LPS-induced up-regulation of iNOS,
COX-2 protein expressions in RAW264.7 macrophages,
indicating that the inhibition of NO and PGE2 produc-
tion by FNP is a result of the inhibition of iNOS and
COX-2 protein expressions. AMPK activation sup-
pressed the LPS-induced expression of pro-inflammatory
cytokines in glial cells [44], vascular endothelial cells [45]
and BV-2 microglia cells [46]. However, AMPK activation
promoted inflammatory cytokines production in in car-
diac fibroblasts of adult mice [47] or human synovial
fibroblast cells [48]. To verify the role of AMPKα in
macrophage, we investigated the phosphorylation of p-
AMPKα/ AMPKα in LPS-induced RAW264.7 cells and
observed a decrease in ratio of p-AMPKα/AMPKα. FNP
pretreatment increase ratio of p-AMPKα/AMPKα, sug-
gesting that the anti-inflammatory activity of FNP was
partly regulated by AMPKα1 subunit.
ERK, JNK and p38, the activation and phosphorylation
of these three subtypes MAPKs play certain roles in
anti-inflammatory mechanism in LPS-induced macro-
phages [49]. Evidence were shown that p38 and ERK are
involved in iNOS production in LPS-induced RAW264.7
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cells [50], while another study showed that p38 and ERK
activation up-regulates LPS-induced COX-2 expression
in RAW264.7 cells [51]. In the present study, our results
observed that FNP pretreatment significantly inhibited
the phosphorylation/activation of JNK and ERK in LPS-
induced RAW264.7 macrophages, while extended
pretreatment to 4 h, stronger inhibiting effect in these
subtypes MAPKs were shown. These results suggesting
suppression of FNP pretreatment on inflammatory me-
diators may be regulated by the ERK and JNK MAPKs
signaling pathways. Moreover, activated JNK induced
phosphorylation of c-JUN in ser73 and ser63. Our re-
sults indicated that FNP pretreatment suppressed phos-
phorylation/activation of c-JUN induced by LPS. Thus,
we can draw a conclusion that anti-inflammatory activ-
ities of FNP may be mediated by inhibiting the phos-
phorylation of JNK, ERK and c-JUN in MAPKs signaling
pathways.
Conclusions
Our present study demonstrated that FNP isolated from
Polygonum hydropiper L. possesses antioxidant and anti-
inflammatory activities. The anti-inflammatory mechan-
ism of FNP might be related to the decrement of the
level of MDA, MPO and ACP via increasing the activ-
ities of T-AOC, T-SOD, GSH-PX and GSH. FNP inhib-
ited iNOS and COX-2 protein expression in LPS-
stimulated RAW264.7 macrophages. The inhibitory ef-
fects of FNP may be mediated by suppression of JNK,
ERK MAPKs signaling pathways.
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